Advanced Search

 

Study ID Status Title Patient Level Data
111982 Completed Post-marketing carcinogenicity study of Bupropion
111983 Completed Fluticasone propionate nasal spray (Flixonase) safety in patients with allergic rhinitis registered in the UK General Practice Research Database
111985 Completed The long-term use of Advair/Seretide and risk of events (incident non-vertebral fracture, glaucoma, and cataracts) among COPD patients in the UK General Research Practice Database
111985_1 Completed The long-term use of Advair/Seretide and risk of events (incident non-vertebral fracture, glaucoma, and cataracts) among COPD patients in the UK General Research Practice Database
111985_2 Completed The long-term use of Advair/Seretide and risk of events (incident non-vertebral fracture, glaucoma, and cataracts) among COPD patients in the UK General Research Practice Database
111985_3 Completed The long-term use of Advair/Seretide and risk of events (incident non-vertebral fracture, glaucoma, and cataracts) among COPD patients in the UK General Research Practice Database
112008 Completed A single-centre, open-label, sequential, cross-over study to examine the safety, tolerability and pharmacokinetics of 3 ascending single intravenous doses, a single 1000μg oral dose and a single 1000μg inhaled dose of GSK573719 in healthy male volunteers. Study Listed on ClinicalStudyDataRequest.com
112014 Completed An open-label, two period study to determine the excretion balance and pharmacokinetics of 14C-GSK573719, administered as single dose of an oral solution and an intravenous infusion, to healthy male adults Study Listed on ClinicalStudyDataRequest.com
112021 Relinquished Long term antibody persistence study of GSK Biologicals’ meningococcal vaccine GSK 134612 administered as 1 or 2 doses to healthy toddlers at 9-12 months of age and as a booster dose at 5 years post-primary vaccination Study Listed on ClinicalStudyDataRequest.com
112022 Completed Immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ Human Papillomavirus (HPV) 580299 vaccine in healthy Chinese female subjects Study Listed on ClinicalStudyDataRequest.com
112024 Completed Gynaecological follow-up of a subset of 580299/008 study subjects
112025 Completed A multi-centre, randomized, double-blind, five-way crossover study evaluating the dose response and duration of action of GSK2190915 compared to placebo in subjects with mild asthma who experience exercise induced bronchoconstriction. Study Listed on ClinicalStudyDataRequest.com
112034 Completed A Two Part Single Dose, Randomized, Balanced, Crossover Study to Assess the Relative Bioavailability of Three Formulations, Drug Interaction and Food Effect on an GSK1322322 in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
112036 Relinquished Persistence of antibodies after GSK Biologicals’ meningococcal vaccine GSK134612 in toddlers Study Listed on ClinicalStudyDataRequest.com
112046 Terminated The efficacy of orally administered GSK2190915 as an add-on to current therapy in subjects with moderate to severe asthma who have elevated sputum neutrophils Study Listed on ClinicalStudyDataRequest.com
112059 Completed A randomised, double-blind, double-dummy, placebo controlled (with rescue medication), multicenter study to evaluate the efficacy and safety of Fluticasone Furoate inhalation powder in the treatment of persistent asthma in adults and adolescents. Study Listed on ClinicalStudyDataRequest.com
112060 Completed A randomized, double-blind, double-dummy, parallel-group, placebo controlled (on inhaled corticosteroid medication), multicenter study to evaluate the efficacy and safety of vilanterol inhalation powder (GW642444) and salmeterol, compared with placebo in the treatment of persistent asthma in adults and adolescents uncontrolled on inhaled corticosteroids Study Listed on ClinicalStudyDataRequest.com
112071 Completed An open-label, randomised, single-dose, multi-cohort, crossover bioavailability study of a solution formulation and three capsule formulations of GSK2190915 in healthy adult subjects followed by a repeat-dose, randomized, parallel group, double-blinded study of one selected capsule formulation and matched placebo in elderly healthy subjects Study Listed on ClinicalStudyDataRequest.com
112110 Relinquished An Open-Label, Dose-Escalation, Phase IB II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination with Oral Everolimus in Subjects with Solid Tumors
112111 Relinquished A Phase IB Combination Study of MEK inhibitor GSK1120212 with Gemcitabine in Subjects with Solid Tumors
112146 Completed A single centre, randomised, placebo-controlled, four-way cross over study to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK233705 and GW642444 as monotherapies and in combination in healthy Japanese subjects Study Listed on ClinicalStudyDataRequest.com
112147 Completed Observer-blind immunogenicity study of GSK Biologicals’ influenza vaccine GSK2186877A in elderly subjects Study Listed on ClinicalStudyDataRequest.com
112148 Relinquished Persistence of antibodies after vaccination with GSK Biologicals’ meningococcal vaccine GSK134612 in adolescents and young adults
112157 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals’ GSK2202083A vaccine in healthy infants at 2, 3 and 4 months of age Study Listed on ClinicalStudyDataRequest.com
112167 Completed An Open Label, Non-Randomized, Single dose, Two Period, Cross-Over, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.